Survival rates of patients with tumors originating in different segments of the left upper lung in stage I to III non-small cell lung cancer
The aim of this research was to evaluate the effect of spatial location of tumors on the prognosis of patients with left upper lung non-small cell lung cancer (NSCLC), with a focus on the S1+2+3 and lingual segment. A total of 486 patients who underwent lobectomy and systematic lymph node dissection...
Saved in:
Published in | Annals of translational medicine Vol. 9; no. 20; p. 1590 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
China
AME Publishing Company
01.10.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The aim of this research was to evaluate the effect of spatial location of tumors on the prognosis of patients with left upper lung non-small cell lung cancer (NSCLC), with a focus on the S1+2+3 and lingual segment.
A total of 486 patients who underwent lobectomy and systematic lymph node dissection were collected retrospectively in this study (354 S1+2+3 and 132 lingual segment patients). Factors impacting survival were assessed via univariate analyses, multivariate analyses, and log-rank tests.
Compared with tumor location in S1+2+3, lingual segment tumor location of stage II to III left upper lung NSCLC patients was significantly associated with a better 5-year disease-free survival (DFS) (P=0.041). Multivariate analysis results showed that tumor location in the lingual segment was a good independent prognostic factor of stage II to III left upper lung NSCLC patients [hazard ratio (HR) =0.602, 95% confidence interval (CI): 0.149-0.865, P=0.006). However, in stage I left upper lung NSCLC, tumor location (HR =1.069, 95% CI: 0.571-2.000, P=0.835) was not an independent prognostic factor, and only T2 (HR =2.422, 95% CI: 1.271-4.620, P=0.007) was an independent worse prognosis factor.
Tumor location in the lingual segment of left upper lung stage II to stage III NSCLC is a good independent prognostic factor compared with S1+2+3. Nevertheless, tumor location does not impact the prognosis of patients with stage I NSCLC in the left upper lung. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. Contributions: (I) Conception and design: Y Xiao, X Yang; (II) Administrative support: S Huang; (III) Provision of study materials or patients: X Yang, Y Xiao, S Luo, J He; (IV) Collection and assembly of data: Y Zhou, W Li; (V) Data analysis and interpretation: Y Xiao, X Yang, J Lan; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. |
ISSN: | 2305-5839 2305-5839 |
DOI: | 10.21037/atm-21-5157 |